⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3710347 | 0.98 | CA2 (0.39) | — | |
| SCHEMBL21670717 | 0.98 | CA2 (0.39) | — | |
| SCHEMBL21962469 | 0.84 | — | — | |
| SCHEMBL22494209 | 0.82 | AKR1B1 (0.35) | — | |
| SCHEMBL329387 | 0.80 | — | — | |
| SCHEMBL440583 | 0.78 | — | — | |
| SCHEMBL4976456 | 0.78 | — | — | |
| SCHEMBL29067528 | 0.78 | ALDH1A1 (0.34) | — | |
| SCHEMBL29492947 | 0.76 | DUSP3 (0.34) | — | |
| Hydrochloric Acid SCHEMBL28129331 | 0.76 | TSHR (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 456 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109633065-B | Method for detecting drug residues in animal body | 沈阳海关技术中心 | 2021-04-20 | — | — | CN | claimed |
| CN-111039982-A | Design and synthesis of pyrazole sulfonamide derivatives containing novel phosphamidon skeleton | 南京大学 | 2020-04-21 | — | — | CN | claimed |
| CN-108473495-A | Purinones as ubiquitin-specific protease 1 inhibitors | 福马治疗有限公司 | 2018-08-31 | — | — | CN | claimed |
| CN-108383828-A | 1 new, 2- as chemokine receptor modulators is bis--sulfamide derivative | 阿勒根公司 | 2018-08-10 | — | — | CN | claimed |
| CN-107674211-A | It is a kind of to be used to prepare high molecular polymer of conducting element and preparation method thereof | 宋宏婷 | 2018-02-09 | — | — | CN | claimed |
| EP-2323987-A1 | N-MYRISTOYL TRANSFERASE INHIBITORS | University of Dundee (GB) | 2011-05-25 | — | — | EP | claimed |
| CN-101805290-A | Aminosulfonyl pyrazol compounds and applications thereof | FOURTH MILITARY MEDICAL UNIV | 2010-08-18 | — | — | CN | claimed |
| WO-2010026365-A1 | N-MYRISTOYL TRANSFERASE INHIBITORS | UNIVERSITY OF DUNDEE (GB) | 2010-03-11 | — | — | WO | claimed |
| EP-2035427-A2 | PYRAZOLO[1,5-A]PYRIMIDINE COMPOUNDS AS CB1 RECEPTOR ANTAGONIST | Mitsubishi Tanabe Pharma Corporation (JP) | 2009-03-18 | — | — | EP | claimed |
| WO-2008004698-A2 | PYRAZOLO [1, 5-A] PYRIMIDINE COMPOUNDS AS CB1 RECEPTOR ANTAGONIST | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2008-01-10 | — | — | WO | claimed |
| EP-0087780-B2 | Pyrazolesulfonylurea derivative, preparation thereof, herbicide containing said derivative as active ingredient and herbicidal method by use thereof | NISSAN CHEMICAL IND LTD (JP) | 1995-02-15 | — | — | EP | claimed |
| EP-0318602-B1 | PYRAZOLESULFONAMIDE DERIVATIVE, PROCESS FOR ITS PRODUCTION AND HERBICIDE CONTAINING IT | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1993-04-28 | — | — | EP | claimed |
| EP-0224842-B1 | PYRAZOLESULFONAMIDE DERIVATIVE, PROCESS FOR ITS PRODUCTION AND HERBICIDE CONTAINING IT | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1992-02-05 | — | — | EP | claimed |
| US-4931081-A | Herbicidal diazoles sulfonamides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-06-05 | — | — | US | claimed |
| US-4844728-A | Pyrazolesulfonamide derivative, and herbicide containing it | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 1989-07-04 | — | — | US | claimed |
| EP-0318602-A1 | Pyrazolesulfonamide derivative, process for its production and herbicide containing it | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1989-06-07 | — | — | EP | claimed |
| EP-0224842-A2 | Pyrazolesulfonamide derivative, process for its production and herbicide containing it | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1987-06-10 | — | — | EP | claimed |
| EP-0189069-A2 | Pyrazolesulfonamide derivative, process for its production and herbicide containing it | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1986-07-30 | — | — | EP | claimed |
| EP-0087780-A2 | Pyrazolesulfonylurea derivative, preparation thereof, herbicide containing said derivative as active ingredient and herbicidal method by use thereof | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1983-09-07 | — | — | EP | claimed |
| JP-6009314-A | — | — | None | — | — | JP | disclosed |
| EP-4739393-A1 | TETRAHYDROQUINAZOLINE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS | Merck Sharp & Dohme LLC (US) | 2026-05-13 | — | — | EP | disclosed |
| US-20250388568-A1 | NLRP3 INHIBITORS | KODIAK SCIENCES INC (US) | 2025-12-25 | — | — | US | disclosed |
| EP-4577536-A1 | PYRAZOLYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY | Hotspot Therapeutics, Inc. (US) | 2025-07-02 | — | — | EP | disclosed |
| EP-4577536-A1 | PYRAZOLYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY | Hotspot Therapeutics, Inc. (US) | 2025-07-02 | — | — | EP | disclosed |
| EP-4577536-A1 | PYRAZOLYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY | Hotspot Therapeutics, Inc. (US) | 2025-07-02 | — | — | EP | disclosed |
| US-12343341-B2 | Synthetic lethality and the treatment of cancer | PACYLEX PHARMACEUTICALS INC. (CA) | 2025-07-01 | — | — | US | disclosed |
| CN-120187714-A | Pyrazolylsulfonamide compounds and their use in therapy | 热点治疗股份有限公司 | 2025-06-20 | — | — | CN | disclosed |
| CN-120187714-A | Pyrazolylsulfonamide compounds and their use in therapy | 热点治疗股份有限公司 | 2025-06-20 | — | — | CN | disclosed |
| US-20250179589-A1 | SYNTHETIC LETHALITY AND THE TREATMENT OF CANCER | PACYLEX PHARMACEUTICALS INC. (CA) | 2025-06-05 | — | — | US | disclosed |
| WO-2025080695-A1 | 1-SULFONYL-3-AMINO-1H-1,2,4-TRIAZOLES AS YELLOW FEVER VIRUS INHIBITORS | COLLABORATIONS PHARMACEUTICALS, INC. (US) | 2025-04-17 | — | — | WO | disclosed |
| CN-113382984-B | Preparation method of N-phenylpyrazole-1-carboxamide | FMC公司 | 2025-03-14 | — | — | CN | disclosed |
| US-12234217-B2 | Method for preparing N-phenylpyrazole-1-carboxamides | FMC CORPORATION (US) | 2025-02-25 | — | — | US | disclosed |
| US-12221434-B2 | Sulfonamide carboxamide compounds | INFLAZOME LIMITED (IE) | 2025-02-11 | — | — | US | disclosed |
| US-20250026759-A1 | TETRAHYDROQUINAZOLINE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS | MERCK SHARP & DOHME LLC (US) | 2025-01-23 | — | — | US | disclosed |
| WO-2025014788-A1 | TETRAHYDROQUINAZOLINE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS | MERCK SHARP & DOHME LLC (US) | 2025-01-16 | — | — | WO | disclosed |
| US-20240400502-A1 | SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME | UNIV QUEENSLAND (AU) | 2024-12-05 | — | — | US | disclosed |
| EP-3953331-B1 | PYRAZOLESULFONAMIDES AS ANTITUMOR AGENTS | PELOTON THERAPEUTICS INC (US) | 2024-11-20 | — | — | EP | disclosed |
| US-20240368189-A1 | Modulators of Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods of Treatment, and Process for Making the Modulators | VERTEX PHARMA (US) | 2024-11-07 | — | — | US | disclosed |
| US-20240350481-A1 | USE OF N-MYRISTOYL TRANSFERASE (NMT) INHIBITORS IN THE TREATMENT OF CANCER, AUTOIMMUNE DISORDERS, AND INFLAMMATORY DISORDERS | PACYLEX PHARMACEUTICALS INC. (CA) | 2024-10-24 | — | — | US | disclosed |
| EP-4408843-A1 | NOVEL SUBSTITUTED SULFONYLUREA COMPOUNDS AS INHIBITORS OF INTERLEUKIN-1 ACTIVITY | Viva Star Biosciences (Suzhou) Co., Ltd. (CN) | 2024-08-07 | — | — | EP | disclosed |
| US-12030879-B2 | Sulfonyl acetamides as NLRP3 inhibitors | INFLAZOME LIMITED (IE) | 2024-07-09 | — | — | US | disclosed |
| CN-118251393-A | Novel substituted sulfonylurea compounds as inhibitors of interleukin-1 activity | 唯久生物技术(苏州)有限公司 | 2024-06-25 | — | — | CN | disclosed |
| US-20240150321-A1 | PYRAZOLYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY | HOTSPOT THERAPEUTICS, INC. | 2024-05-09 | — | — | US | disclosed |
| US-20240150321-A1 | PYRAZOLYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY | HOTSPOT THERAPEUTICS, INC. | 2024-05-09 | — | — | US | disclosed |
| US-20240150321-A1 | PYRAZOLYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY | HOTSPOT THERAPEUTICS, INC. | 2024-05-09 | — | — | US | disclosed |
| CN-114585628-B | Modulators of cystic fibrosis transmembrane conductance regulator | 弗特克斯药品有限公司 | 2024-03-26 | — | — | CN | disclosed |
| WO-2024044730-A1 | PYRAZOLYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY | HOTSPOT THERAPEUTICS, INC. (US) | 2024-02-29 | — | — | WO | disclosed |
| WO-2024044730-A1 | PYRAZOLYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY | HOTSPOT THERAPEUTICS, INC. (US) | 2024-02-29 | — | — | WO | disclosed |
| WO-2024044730-A1 | PYRAZOLYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY | HOTSPOT THERAPEUTICS, INC. (US) | 2024-02-29 | — | — | WO | disclosed |
| US-11884645-B2 | Sulfonyl acetamides as NLRP3 inhibitors | INFLAZOME LIMITED (IE) | 2024-01-30 | — | — | US | disclosed |
| US-11866450-B2 | Modulators of Cystic Fibrosis Transmembrane Conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2024-01-09 | — | — | US | disclosed |
| CN-220299158-U | High leakproofness storage device of pyrazosulfuron ethyl | 怀仁诚隆化工科技有限公司 | 2024-01-05 | — | — | CN | disclosed |
| CN-117285547-A | Macrocyclic compounds as modulators of CFTR, pharmaceutical compositions thereof, their use and methods of preparation | 弗特克斯药品有限公司 | 2023-12-26 | — | — | CN | disclosed |
| US-20230374603-A1 | SYNTHETIC LETHALITY AND THE TREATMENT OF CANCER | PACYLEX PHARMACEUTICALS INC. (CA) | 2023-11-23 | — | — | US | disclosed |
| CN-110974967-B | Synthetic mortality and cancer treatment | 厄尔莱克斯制药公司 | 2023-11-07 | — | — | CN | disclosed |
| US-11788145-B2 | Epigeneiic silencing of NMT2 | PACYLEX PHARMACEUTICALS INC. (CA) | 2023-10-17 | — | — | US | disclosed |
| CN-116710461-A | Sulfonylurea NLRP3 inflammation corpuscle inhibitor | 维纳拓尔斯制药公司 | 2023-09-05 | — | — | CN | disclosed |
| EP-3325662-B1 | EPIGENETIC SILENCING OF NMT2 | PACYLEX PHARMACEUTICALS INC (CA) | 2023-08-30 | — | — | EP | disclosed |
| EP-4232032-A1 | USE OF N-MYRISTOYL TRANSFERASE (NMT) INHIBITORS IN THE TREATMENT OF CANCER, AUTOIMMUNE DISORDERS, AND INFLAMMATORY DISORDERS | Pacylex Pharmaceuticals Inc. (CA) | 2023-08-30 | — | — | EP | disclosed |
| CN-111741956-B | Antiparasitic depsipeptides | 硕腾服务有限责任公司 | 2023-07-07 | — | — | CN | disclosed |
| CN-112004817-B | Macrocyclic compounds as modulators of CFTR, pharmaceutical compositions thereof, their use and methods of preparation | 弗特克斯药品有限公司 | 2023-06-23 | — | — | CN | disclosed |
| EP-4198037-A1 | MACROCYCLES AS MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, PHARMACEUTICAL COMPOSITIONS THEREOF AND THEIR USE IN THE TREATMENT OF CYCSTIC FIBROSIS | Vertex Pharmaceuticals Incorporated (US) | 2023-06-21 | — | — | EP | disclosed |
| EP-4198037-A1 | MACROCYCLES AS MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, PHARMACEUTICAL COMPOSITIONS THEREOF AND THEIR USE IN THE TREATMENT OF CYCSTIC FIBROSIS | Vertex Pharmaceuticals Incorporated (US) | 2023-06-21 | — | — | EP | disclosed |
| CN-116234547-A | Use of inhibitors of N-myristoyltransferase (NMT) in the treatment of cancer, autoimmune disorders and inflammatory disorders | 厄尔莱克斯制药公司 | 2023-06-06 | — | — | CN | disclosed |
| WO-2023056264-A1 | NOVEL SUBSTITUTED SULFONYLUREA COMPOUNDS AS INHIBITORS OF INTERLEUKIN-1 ACTIVITY | VIVA STAR BIOSCIENCES (SUZHOU) CO., LTD. (CN) | 2023-04-06 | — | — | WO | disclosed |
| US-20230104936-A1 | TRPML MODULATORS | CASMA THERAPEUTICS, INC. | 2023-04-06 | — | — | US | disclosed |
| US-11613542-B2 | Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors | INFLAZOME LIMITED (IE) | 2023-03-28 | — | — | US | disclosed |
| US-11542255-B2 | Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors | INFLAZOME LIMITED (IE) | 2023-01-03 | — | — | US | disclosed |
| EP-3953331-A4 | PYRAZOLESULFONAMIDES AS ANTITUMOR AGENTS | Peloton Therapeutics, Inc. (US) | 2022-12-28 | — | — | EP | disclosed |
| US-11530200-B2 | Compounds | INFLAZOME LIMITED (IE) | 2022-12-20 | — | — | US | disclosed |
| EP-3752510-B1 | MACROCYCLES AS MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, PHARMACEUTICAL COMPOSITIONS THEREOF, THEIR USE IN THE TREATMENT OF CYCSTIC FIBROSIS, AND PROCESS FOR MAKING THEM | VERTEX PHARMA (US) | 2022-12-07 | — | — | EP | disclosed |
| EP-3752510-B1 | MACROCYCLES AS MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, PHARMACEUTICAL COMPOSITIONS THEREOF, THEIR USE IN THE TREATMENT OF CYCSTIC FIBROSIS, AND PROCESS FOR MAKING THEM | VERTEX PHARMA (US) | 2022-12-07 | — | — | EP | disclosed |
| EP-2734199-B1 | SYNTHETIC LETHALITY AND THE TREATMENT OF CANCER | PACYLEX PHARMACEUTICALS INC (CA) | 2022-11-16 | — | — | EP | disclosed |
| US-20220313698-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMACEUTICALS INCORPORATED | 2022-10-06 | — | — | US | disclosed |
| US-20220289766-A1 | MACROCYCLIC SULFONYLUREA DERIVATIVES USEFUL AS NLRP3 INHIBITORS | INFLAZOME LIMITED (IE) | 2022-09-15 | — | — | US | disclosed |
| EP-4013759-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | Vertex Pharmaceuticals Incorporated (US) | 2022-06-22 | — | — | EP | disclosed |
| CN-114585628-A | Modulators of cystic fibrosis transmembrane conductance regulator | 弗特克斯药品有限公司 | 2022-06-03 | — | — | CN | disclosed |
| WO-2022082306-A1 | USE OF N-MYRISTOYL TRANSFERASE (NMT) INHIBITORS IN THE TREATMENT OF CANCER, AUTOIMMUNE DISORDERS, AND INFLAMMATORY DISORDERS | PACYLEX PHARMACEUTICALS INC. (CA) | 2022-04-28 | — | — | WO | disclosed |
| CN-114401971-A | Macrocyclic sulfonylurea derivatives as NLRP3 inhibitors | 英夫拉索姆有限公司 | 2022-04-26 | — | — | CN | disclosed |
| US-11304924-B2 | Pharmaceutical compositions comprising nitroxyl donors | CARDIOXYL PHARMACEUTICALS, INC. (US) | 2022-04-19 | — | — | US | disclosed |
| US-20220112159-A1 | SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME | UNIV QUEENSLAND (AU) | 2022-04-14 | — | — | US | disclosed |
| US-20220106289-A1 | NLRP3 INHIBITORS | INFLAZOME LIMITED (IE) | 2022-04-07 | — | — | US | disclosed |
| US-20220106289-A1 | NLRP3 INHIBITORS | INFLAZOME LIMITED (IE) | 2022-04-07 | — | — | US | disclosed |
| US-20220106331-A1 | Modulators of Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods of Treatment, and Process for Making the Modulators | VERTEX PHARMACEUTICALS INCORPORATED | 2022-04-07 | — | — | US | disclosed |
| US-20220056007-A1 | METHOD FOR PREPARING N-PHENYLPYRAZOLE-1-CARBOXAMIDES | FMC IP TECHNOLOGY GMBH (CH) | 2022-02-24 | — | — | US | disclosed |
| CN-110551122-B | Substituted pyrazolyl pyrazole sulfonamide compound or salt and composition thereof acceptable as pesticide and application thereof | 海利尔药业集团股份有限公司 | 2022-02-18 | — | — | CN | disclosed |
| US-20220023294-A1 | SYNTHETIC LETHALITY AND THE TREATMENT OF CANCER | PACYLEX PHARMACEUTICALS INC. (CA) | 2022-01-27 | — | — | US | disclosed |
| EP-3891131-A1 | METHOD FOR PREPARING N-PHENYLPYRAZOLE-1-CARBOXAMIDES | FMC CORPORATION (US) | 2021-10-13 | — | — | EP | disclosed |
| EP-3883646-A1 | NLRP3 INHIBITORS | Inflazome Limited (IE) | 2021-09-29 | — | — | EP | disclosed |
| CN-113382984-A | Process for preparing N-phenylpyrazole-1-carboxamides | FMC公司 | 2021-09-10 | — | — | CN | disclosed |
| CN-113286784-A | Compounds and compositions for treating conditions associated with NLRP activity | 诺华股份有限公司 | 2021-08-20 | — | — | CN | disclosed |
| EP-3858350-A1 | SYNTHETIC LETHALITY AND THE TREATMENT OF CANCER | Pacylex Pharmaceuticals Inc. (CA) | 2021-08-04 | — | — | EP | disclosed |
| CN-113166065-A | Compounds and compositions for treating conditions associated with NLRP activity | 诺华股份有限公司 | 2021-07-23 | — | — | CN | disclosed |
| CN-113164763-A | NLRP3 inhibitor | 英夫拉索姆有限公司 | 2021-07-23 | — | — | CN | disclosed |
| US-11066417-B2 | Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2021-07-20 | — | — | US | disclosed |
| US-11066417-B2 | Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2021-07-20 | — | — | US | disclosed |
| US-20210130359-A1 | SULFONYLUREAS AND SULFONYLTHIOUREAS AS NLRP3 INHIBITORS | INFLAZOME LIMITED (IE) | 2021-05-06 | — | — | US | disclosed |
| WO-2021030556-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2021-02-18 | — | — | WO | disclosed |
| WO-2021030556-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2021-02-18 | — | — | WO | disclosed |
| CN-111056978-B | Sulfonamide compound and preparation method and application thereof | 西安交通大学 | 2021-01-19 | — | — | CN | disclosed |
| EP-3752510-A1 | MACROCYCLES AS MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, PHARMACEUTICAL COMPOSITIONS THEREOF, THEIR USE IN THE TREATMENT OF CYCSTIC FIBROSIS, AND PROCESS FOR MAKING THEM | Vertex Pharmaceuticals Incorporated (US) | 2020-12-23 | — | — | EP | disclosed |
| EP-2914261-B1 | SYNTHETIC LETHALITY AND THE TREATMENT OF CANCER | PACYLEX PHARMACEUTICALS INC (CA) | 2020-12-16 | — | — | EP | disclosed |
| CN-112020495-A | N- ((1,2,3,5,6, 7-hexahydro-sym-indacen-4-yl) carbamoyl) -1-isopropyl-1H-pyrazole-3-sulfonamide sodium salt | 英夫拉索姆有限公司 | 2020-12-01 | — | — | CN | disclosed |
| CN-112004817-A | Macrocyclic compounds as modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions thereof, their use in the treatment of cystic fibrosis, and processes for their preparation | 弗特克斯药品有限公司 | 2020-11-27 | — | — | CN | disclosed |
| US-20200361895-A1 | NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS | INFLAZOME LIMITED (IE) | 2020-11-19 | — | — | US | disclosed |
| EP-3707134-A1 | NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS | Inflazome Limited (IE) | 2020-09-16 | — | — | EP | disclosed |
| CN-111423376-A | Isopimaric acyl heterocyclic sulfonamide derivative and preparation method and application thereof | 中国林业科学研究院林产化学工业研究所 | 2020-07-17 | — | — | CN | disclosed |
| EP-3668861-A1 | NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS | Inflazome Limited (IE) | 2020-06-24 | — | — | EP | disclosed |
| EP-3668599-A1 | SULFONYLUREAS AND SULFONYLTHIOUREAS AS NLRP3 INHIBITORS | Inflazome Limited (IE) | 2020-06-24 | — | — | EP | disclosed |
| WO-2020117493-A1 | METHOD FOR PREPARING N-PHENYLPYRAZOLE-1-CARBOXAMIDES | FMC CORPORATION (US) | 2020-06-11 | — | — | WO | disclosed |
| US-20200163929-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING NITROXYL DONORS | CARDIOXYL PHARMACEUTICALS, INC. | 2020-05-28 | — | — | US | disclosed |
| WO-2020102096-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY | NOVARTIS INFLAMMASOME RESEARCH, INC. (US) | 2020-05-22 | — | — | WO | disclosed |
| CN-111056978-A | Sulfonamide compound and preparation method and application thereof | 西安交通大学 | 2020-04-24 | — | — | CN | disclosed |
| WO-2020079207-A1 | NOVEL PROCESSES | INFLAZOME LIMITED (IE) | 2020-04-23 | — | — | WO | disclosed |
| CN-111039982-A | Design and synthesis of pyrazole sulfonamide derivatives containing novel phosphamidon skeleton | 南京大学 | 2020-04-21 | — | — | CN | disclosed |
| CN-111039982-A | Design and synthesis of pyrazole sulfonamide derivatives containing novel phosphamidon skeleton | 南京大学 | 2020-04-21 | — | — | CN | disclosed |
| CN-111039982-A | Design and synthesis of pyrazole sulfonamide derivatives containing novel phosphamidon skeleton | 南京大学 | 2020-04-21 | — | — | CN | disclosed |
| CN-110974967-A | Synthetic lethality and treatment of cancer | 厄尔莱克斯制药公司 | 2020-04-10 | — | — | CN | disclosed |
| EP-3606909-A1 | A SODIUM SALT OF N-((1,2,3,5,6,7-HEXAHYDRO-S-INDACEN-4-YL)CARBAMOYL)-1 -ISOPROPYL-1 H-PYRAZOLE-3-SULFONAMIDE | Inflazome Limited (IE) | 2020-02-12 | — | — | EP | disclosed |
| US-10548872-B2 | Pharmaceutical compositions comprising nitroxyl donors | CARDIOXYL PHARMACEUTICALS, INC. (US) | 2020-02-04 | — | — | US | disclosed |
| WO-2019233372-A1 | SUBSTITUTED PYRAZOLYL PYRAZOLE SULFONAMIDE COMPOUND OR PESTICIDALLY ACCEPTABLE SALT THEREOF, COMPOSITION AND USE THEREOF | 海利尔药业集团股份有限公司 (CN) | 2019-12-12 | — | — | WO | disclosed |
| CN-110551122-A | Substituted pyrazolyl pyrazole sulfonamide compound or salt and composition thereof acceptable as pesticide and application thereof | QINGDAO HAILIR PESTICIDES & CHEMICALS GROUP CO LTD | 2019-12-10 | — | — | CN | disclosed |
| CN-110179777-A | Medical composition comprising nitroxyl donors | 卡尔迪奥克斯尔制药公司 | 2019-08-30 | — | — | CN | disclosed |
| WO-2019161078-A1 | MACROCYCLES AS MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, PHARMACEUTICAL COMPOSITIONS THEREOF, THEIR USE IN THE TREATMENT OF CYCSTIC FIBROSIS, AND PROCESS FOR MAKING THEM | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2019-08-22 | — | — | WO | disclosed |
| WO-2019161078-A1 | MACROCYCLES AS MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, PHARMACEUTICAL COMPOSITIONS THEREOF, THEIR USE IN THE TREATMENT OF CYCSTIC FIBROSIS, AND PROCESS FOR MAKING THEM | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2019-08-22 | — | — | WO | disclosed |
| US-20190248809-A1 | Modulators of Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods of Treatment, and Process for Making the Modulators | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2019-08-15 | — | — | US | disclosed |
| US-20190248809-A1 | Modulators of Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods of Treatment, and Process for Making the Modulators | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2019-08-15 | — | — | US | disclosed |
| CN-106632045-B | Pyrazoles sulfamide compound and its preparation method and use | 江苏富鼎化学有限公司 | 2019-08-13 | — | — | CN | disclosed |
| CN-106632045-B | Pyrazoles sulfamide compound and its preparation method and use | 江苏富鼎化学有限公司 | 2019-08-13 | — | — | CN | disclosed |
| CN-106632045-B | Pyrazoles sulfamide compound and its preparation method and use | 江苏富鼎化学有限公司 | 2019-08-13 | — | — | CN | disclosed |
| US-20190224159-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING NITROXYL DONORS | CARDIOXYL PHARMACEUTICALS, INC. | 2019-07-25 | — | — | US | disclosed |
| CN-106866532-B | The synthetic method of pyrazosulfuron intermediate 4- carbethoxyl group -5- sulfoamido -1- methylpyrazole | 江苏省农用激素工程技术研究中心有限公司 | 2019-06-25 | — | — | CN | disclosed |
| CN-105142627-B | Pharmaceutical compositions comprising nitroxyl donors | 卡尔迪奥克斯尔制药公司 | 2019-06-21 | — | — | CN | disclosed |
| CN-105308036-B | The Compounds and methods for and its indication adjusted for kinases | 普莱希科公司 | 2019-06-21 | — | — | CN | disclosed |
| US-10245249-B2 | Pharmaceutical compositions comprising nitroxyl donors | CARDIOXYL PHARMACEUTICALS, INC. (US) | 2019-04-02 | — | — | US | disclosed |
| WO-2019043372-A1 | SUBSTITUTES SULFONYL AZACYCLES AS MODULATORS OF HEDGEHOG (HH) SIGNALLING PATHWAY | E-THERAPEUTICS PLC (GB) | 2019-03-07 | — | — | WO | disclosed |
| WO-2019034690-A1 | SULFONYLUREAS AND SULFONYLTHIOUREAS AS NLRP3 INHIBITORS | INFLAZOME LIMITED (IE) | 2019-02-21 | — | — | WO | disclosed |
| WO-2019034686-A1 | NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS | INFLAZOME LIMITED (IE) | 2019-02-21 | — | — | WO | disclosed |
| US-20190010555-A1 | SYNTHETIC LETHALITY AND THE TREATMENT OF CANCER | PACYLEX PHARMACEUTICALS INC. (CA) | 2019-01-10 | — | — | US | disclosed |
| EP-3416948-A1 | SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME | The University Of Queensland (AU) | 2018-12-26 | — | — | EP | disclosed |
| CN-109071454-A | Sulfonylureas and related compound and application thereof | 昆士兰大学 | 2018-12-21 | — | — | CN | disclosed |
| CN-106866710-B | Ultrasonic wave one kettle way prepares the method and application of pyrazoles sulfonamides sodium, potassium, calcium metal complex | 中南民族大学 | 2018-11-20 | — | — | CN | disclosed |
| CN-108383828-A | 1 new, 2- as chemokine receptor modulators is bis--sulfamide derivative | 阿勒根公司 | 2018-08-10 | — | — | CN | disclosed |
| CN-107646036-A | Pyrazole derivatives useful as inhibitors of 5-lipoxygenase activating protein (F L AP) | 阿斯利康(瑞典)有限公司 | 2018-01-30 | — | — | CN | disclosed |
| CN-107531686-A | Pseudomonas aeruginosa LecB inhibitor | 亥姆霍兹感染研究中心有限责任公司 | 2018-01-02 | — | — | CN | disclosed |
| EP-3259253-A1 | SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME | The University of Queensland (AU) | 2017-12-27 | — | — | EP | disclosed |
| CN-107428696-A | Sulfonylureas and related compounds and uses thereof | 昆士兰大学 | 2017-12-01 | — | — | CN | disclosed |
| US-9828346-B2 | N-myristoyl transferase inhibitors | UNIVERSITY OF DUNDEE (GB) | 2017-11-28 | — | — | US | disclosed |
| WO-2017140778-A1 | SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME | THE UNIVERSITY OF QUEENSLAND (AU) | 2017-08-24 | — | — | WO | disclosed |
| US-9718784-B2 | Substituted pyrazoles as heat shock transcription factor activators | DUKE UNIVERSITY (US) | 2017-08-01 | — | — | US | disclosed |
| US-9717709-B2 | Substituted pyrazoles as heat shock transcription factor activators | DUKE UNIVERSITY (US) | 2017-08-01 | — | — | US | disclosed |
| CN-106866710-A | Ultrasonic wave one kettle way prepares pyrazoles sulfonamides sodium, potassium, the method for calcium metal complex and application | 中南民族大学 | 2017-06-20 | — | — | CN | disclosed |
| CN-106866532-A | The synthetic method of the methylpyrazole of 4 carbethoxyl group of pyrazosulfuron intermediate, 5 sulfoamido 1 | 江苏省农用激素工程技术研究中心有限公司 | 2017-06-20 | — | — | CN | disclosed |
| CN-106632045-A | Pyrazole sulfamide compound as well as synthesis method and application thereof | 江苏富鼎化学有限公司 | 2017-05-10 | — | — | CN | disclosed |
| CN-106632045-A | Pyrazole sulfamide compound as well as synthesis method and application thereof | 江苏富鼎化学有限公司 | 2017-05-10 | — | — | CN | disclosed |
| CN-106632045-A | Pyrazole sulfamide compound as well as synthesis method and application thereof | 江苏富鼎化学有限公司 | 2017-05-10 | — | — | CN | disclosed |
| US-20170000768-A1 | COMPOSITIONS AND METHODS RELATING TO HEAT SHOCK TRANSCRIPTION FACTOR ACTIVATING COMPOUNDS AND TARGETS THEREOF | CHAPERONE THERAPEUTICS, INC. | 2017-01-05 | — | — | US | disclosed |
| US-9447058-B2 | Substituted 1,3-thiazoles as heat shock transcription factor 1 activators | DUKE UNIVERSITY (US) | 2016-09-20 | — | — | US | disclosed |
| WO-2016131098-A1 | SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME | THE UNIVERSITY OF QUEENSLAND (AU) | 2016-08-25 | — | — | WO | disclosed |
| US-20160221958-A1 | SUBSTITUTED PYRAZOLES AS HEAT SHOCK TRANSCRIPTION FACTOR ACTIVATORS | DUKE UNIVERSITY | 2016-08-04 | — | — | US | disclosed |
| US-9315449-B2 | Substituted pyrazoles as heat shock transcription factor activators | DUKE UNIVERSITY (US) | 2016-04-19 | — | — | US | disclosed |
| CN-103764652-B | Tricyclic pyrazole sulfonamide compounds and preparation and application thereof | ZAFGEN CORP. (US) | 2016-03-23 | — | — | CN | disclosed |
| CN-103764652-B | Tricyclic pyrazole sulfonamide compounds and preparation and application thereof | ZAFGEN CORP. (US) | 2016-03-23 | — | — | CN | disclosed |
| US-20160060224-A1 | N-MYRISTOYL TRANSFERASE INHIBITORS | UNIVERSITY OF DUNDEE (GB) | 2016-03-03 | — | — | US | disclosed |
| EP-2980076-A1 | PYRAZOLYL DERIVATIVES | University of Dundee (GB) | 2016-02-03 | — | — | EP | disclosed |
| EP-2980076-A1 | PYRAZOLYL DERIVATIVES | University of Dundee (GB) | 2016-02-03 | — | — | EP | disclosed |
| US-20160024035-A1 | COMPOSITIONS AND METHODS RELATING TO HEAT SHOCK TRANSCRIPTION FACTOR ACTIVATING COMPOUNDS AND TARGETS THEREOF | DUKE UNIVERSITY | 2016-01-28 | — | — | US | disclosed |
| US-9242997-B2 | Tricyclic pyrazole sulphonamide compunds and methods of making and using same | ZAFGEN, INC. (US) | 2016-01-26 | — | — | US | disclosed |
| US-20150366977-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING NITROXYL DONORS | CARDIOXYL PHARMACEUTICALS, INC. | 2015-12-24 | — | — | US | disclosed |
| US-9156811-B2 | N-myristoyl transferase inhibitors | Univeristy of Dundee (GB) | 2015-10-13 | — | — | US | disclosed |
| US-9156775-B2 | Substituted 1,3-thiazoles as heat shock transcription factor 1 activators | DUKE UNIVERSITY (US) | 2015-10-13 | — | — | US | disclosed |
| US-20150275309-A1 | SYNTHETIC LETHALITY AND THE TREATMENT OF CANCER | PACYLEX PHARMACEUTICALS INC. (CA) | 2015-10-01 | — | — | US | disclosed |
| EP-2914261-A1 | SYNTHETIC LETHALITY AND THE TREATMENT OF CANCER | Pacylex Pharmaceuticals Inc. (CA) | 2015-09-09 | — | — | EP | disclosed |
| CN-102695710-B | Tricyclic pyrazole sulfonamide derivatives | MERCK SERONO S.A. (CH) | 2015-08-19 | — | — | CN | disclosed |
| CN-102695710-B | Tricyclic pyrazole sulfonamide derivatives | MERCK SERONO S.A. (CH) | 2015-08-19 | — | — | CN | disclosed |
| CN-104271574-A | Heterocyclic compounds | TAKEDA PHARMACEUTICAL | 2015-01-07 | — | — | CN | disclosed |
| CN-102471206-B | Novel herbicides | SYNGENTA LTD | 2014-08-20 | — | — | CN | disclosed |
| WO-2014067002-A1 | SYNTHETIC LETHALITY AND THE TREATMENT OF CANCER | PACYLEX PHARMACEUTICALS INC. (CA) | 2014-05-08 | — | — | WO | disclosed |
| CN-103764652-A | Tricyclic pyrazole sulfonamide compounds and methods of making and using same | ZAFGEN CORP | 2014-04-30 | — | — | CN | disclosed |
| CN-103764652-A | Tricyclic pyrazole sulfonamide compounds and methods of making and using same | ZAFGEN CORP | 2014-04-30 | — | — | CN | disclosed |
| US-8680270-B2 | Metallo-oxidoreductase inhibitors using metal binding moieties in combination with targeting moieties | VIAMET PHARMACEUTICALS, INC. (US) | 2014-03-25 | — | — | US | disclosed |
| US-20140080822-A1 | Tricyclic Pyrazole Sulphonamide Compounds and Methods of Making and Using Same | ZAFGEN, INC. (US) | 2014-03-20 | — | — | US | disclosed |
| US-20130267543-A1 | COMPOSITIONS AND METHODS RELATING TO HEAT SHOCK TRANSCRIPTION FACTOR ACTIVATING COMPOUNDS AND TARGETS THEREOF | CHAPERONE THERAPEUTICS, INC. (US) | 2013-10-10 | — | — | US | disclosed |
| EP-2637658-A1 | COMPOSITIONS AND METHODS RELATING TO HEAT SHOCK TRANSCRIPTION FACTOR ACTIVATING COMPOUNDS AND TARGETS THEREOF | Duke University (US) | 2013-09-18 | — | — | EP | disclosed |
| EP-2086546-B1 | METALLO-OXIDOREDUCTASE INHIBITORS USING METAL BINDING MOIETIES IN COMBINATION WITH TARGETING MOIETIES | VIAMET PHARMACEUTICALS INC (US) | 2013-07-10 | — | — | EP | disclosed |
| CN-102695710-A | Tricyclic pyrazol amine derivatives | MERCK SERONO SA | 2012-09-26 | — | — | CN | disclosed |
| CN-102532126-A | 2-substituted-4-chloro-5-[5-subtsituted amino-2-(1,3,4-thiadiazole)-sulfydryl]-3(2H)- pyridazinone derivatives, and preparation method and application thereof | UNIV GUIZHOU | 2012-07-04 | — | — | CN | disclosed |
| WO-2012064715-A1 | COMPOSITIONS AND METHODS RELATING TO HEAT SHOCK TRANSCRIPTION FACTOR ACTIVATING COMPOUNDS AND TARGETS THEREOF | DUKE UNIVERSITY (US) | 2012-05-18 | — | — | WO | disclosed |
| CN-101484448-B | Pyrazole alkanamide substituted thiophenes as AMPA potentiators | ORGANON NV | 2012-03-14 | — | — | CN | disclosed |
| US-20110312921-A1 | N-Myristoyl Transferase Inhibitors | DUNDEE, UNIVERSITY OF (GB) | 2011-12-22 | — | — | US | disclosed |
| WO-2011123678-A2 | SUBSTITUTED BENZO-PYRIDO-TRIAZOLO-DIAZEPINE COMPOUNDS | ARQULE, INC. (US) | 2011-10-06 | — | — | WO | disclosed |
| EP-2349260-A1 | JANUS KINASE INHIBITORS FOR TREATMENT OF DRY EYE AND OTHER EYE RELATED DISEASES | Incyte Corporation (US) | 2011-08-03 | — | — | EP | disclosed |
| EP-2323987-A1 | N-MYRISTOYL TRANSFERASE INHIBITORS | University of Dundee (GB) | 2011-05-25 | — | — | EP | disclosed |
| US-20110112073-A1 | COMPOSITIONS AND METHODS RELATING TO HEAT SHOCK TRANSCRIPTION FACTOR ACTIVATING COMPOUNDS AND TARGETS THEREOF | DUKE UNIVERSITY (US) | 2011-05-12 | — | — | US | disclosed |
| US-7858658-B2 | Fluoro- and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof | WYETH LLC (US) | 2010-12-28 | — | — | US | disclosed |
| US-20100305078-A1 | METALLO-OXIDOREDUCTASE INHIBITORS USING METAL BINDING MOIETIES IN COMBINATION WITH TARGETING MOIETIES | VIAMET PHARMACEUTICALS, INC. (US) | 2010-12-02 | — | — | US | disclosed |
| US-7838550-B2 | Selective N-sulfonylation of 2-amino fluoro- and trifluoroalkyl substituted alcohols | WYETH LLC (US) | 2010-11-23 | — | — | US | disclosed |
| CN-1615295-B | Compounds for the treatment of inflammation, diabetes and related disorders | THERACOS INC | 2010-11-03 | — | — | CN | disclosed |
| US-20100267747-A1 | 5-(Arylsulfonyl)-Pyrazolopiperidines | ELAN PHARMACEUTICALS, INC. (US) | 2010-10-21 | — | — | US | disclosed |
| CN-101805290-A | Aminosulfonyl pyrazol compounds and applications thereof | FOURTH MILITARY MEDICAL UNIV | 2010-08-18 | — | — | CN | disclosed |
| US-20100152294-A1 | Assays For Detecting Inhibitors Of Binding Between COX-2 And PDZ Proteins | ARBOR VITA CORPORATION (US) | 2010-06-17 | — | — | US | disclosed |
| US-7732609-B2 | 5-(arylsulfonyl)-pyrazolopiperidines | ELAN PHARMACEUTICALS, INC. (US) | 2010-06-08 | — | — | US | disclosed |
| WO-2010039939-A1 | JANUS KINASE INHIBITORS FOR TREATMENT OF DRY EYE AND OTHER EYE RELATED DISEASES | INCYTE CORPORATION (US) | 2010-04-08 | — | — | WO | disclosed |
| US-7687666-B2 | Methods for preparing sulfonamide substituted alcohols and intermediates thereof | WYETH (US) | 2010-03-30 | — | — | US | disclosed |
| WO-2010026365-A1 | N-MYRISTOYL TRANSFERASE INHIBITORS | UNIVERSITY OF DUNDEE (GB) | 2010-03-11 | — | — | WO | disclosed |
| US-7671074-B2 | Sulfonylguanidine compounds and pharmaceutical uses thereof | GRUENENTHAL GMBH (DE) | 2010-03-02 | — | — | US | disclosed |
| EP-2150255-A1 | QUINOXALINE DERIVATIVES AS P13 KINASE INHIBITORS | Smithkline Beecham Corporation (US) | 2010-02-10 | — | — | EP | disclosed |
| US-7659312-B2 | Inhibitors of Aquaporin 4, methods and uses thereof | NIIGATA UNIVERSITY (JP) | 2010-02-09 | — | — | US | disclosed |
| US-7659312-B2 | Inhibitors of Aquaporin 4, methods and uses thereof | NIIGATA UNIVERSITY (JP) | 2010-02-09 | — | — | US | disclosed |
| US-20100022568-A1 | ENDOTHELIN RECEPTOR ANTAGONISTS FOR EARLY STAGE IDIOPATHIC PULMONARY FIBROSIS | Actelion Pharmaceeuticals Ltd. (CH) | 2010-01-28 | — | — | US | disclosed |
| CN-101578263-A | Sulfonamides and their use as a medicament | GENETICS CO INC (CH) | 2009-11-11 | — | — | CN | disclosed |
| US-7588911-B2 | Assays for detecting inhibitors of binding between COX-2 and PDZ proteins | ARBOR VITA CORPORATION (US) | 2009-09-15 | — | — | US | disclosed |
| US-20090227667-A1 | FLUORO- AND TRIFLUOROALKYL-CONTAINING HETEROCYCLIC SULFONAMIDE INHIBITORS OF BETA AMYLOID PRODUCTION AND DERIVATIVES THEREOF | WYETH (US) | 2009-09-10 | — | — | US | disclosed |
| EP-2086546-A2 | METALLO-OXIDOREDUCTASE INHIBITORS USING METAL BINDING MOIETIES IN COMBINATION WITH TARGETING MOIETIES | Viamet Pharmaceuticals, Inc. (US) | 2009-08-12 | — | — | EP | disclosed |
| CN-100522151-C | Compounds for treating inflammation, diabetes and related diseases | THERACOS INC (US) | 2009-08-05 | — | — | CN | disclosed |
| CN-101484448-A | Pyrazolealkanamide substituted thiophenes as AMPA potentiators | ORGANON NV (NL) | 2009-07-15 | — | — | CN | disclosed |
| US-7547725-B2 | Fluoro- and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof | WYETH (US) | 2009-06-16 | — | — | US | disclosed |
| US-20090131412-A1 | NOVEL 2-QUINOLONE DERIVATIVE | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2009-05-21 | — | — | US | disclosed |
| US-7528260-B2 | Method for preparing N-phenylpyrazole-1-carboxamides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2009-05-05 | — | — | US | disclosed |
| CN-101415670-A | Methods for preparing sulfonamide substituted alcohols and intermediates thereof | WYETH CORP (US) | 2009-04-22 | — | — | CN | disclosed |
| EP-1794148-B1 | NOVEL PHTHALAZINONE DERIVATIVES, AS AURORA-A KINASE INHIBITORS | HOFFMANN LA ROCHE (CH) | 2009-04-15 | — | — | EP | disclosed |
| US-7501410-B2 | Methods of inhibiting BTK and SYK protein kinases | ROCHE PALO ALTO LLC (US) | 2009-03-10 | — | — | US | disclosed |
| CN-101370776-A | 5-(arylsulfonyl)-pyrazolopiperidines | ELAN PHARM INC (US) | 2009-02-18 | — | — | CN | disclosed |
| EP-1910552-A4 | METHODS AND COMPOSITIONS FOR MODULATING COX | ARBOR VITA CORP (US) | 2009-01-07 | — | — | EP | disclosed |
| EP-1998777-A1 | METHODS OF INHIBITING BTK AND SYK PROTEIN KINASES | F. Hoffmann-La Roche AG (CH) | 2008-12-10 | — | — | EP | disclosed |
| WO-2008141065-A1 | QUINOXALINE DERIVATIVES AS P13 KINASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2008-11-20 | — | — | WO | disclosed |
| EP-1984347-A1 | SELECTIVE N-SULFONYLATION OF 2-AMINO TRIFLUOROALKYL SUBSTITUTED ALCOHOLS | Wyeth a Corporation of the State of Delaware (US) | 2008-10-29 | — | — | EP | disclosed |
| EP-1984321-A1 | METHODS FOR PREPARING SULFONAMIDE SUBSTITUTED ALCOHOLS AND INTERMEDIATES THEREOF | Wyeth (US) | 2008-10-29 | — | — | EP | disclosed |
| US-7439256-B2 | (Arylamidoaryl) cyanoguanidine compounds | OSI PHARMACEUTICALS, INC. | 2008-10-21 | — | — | US | disclosed |
| EP-1288206-B1 | Substituted benzenesulfonamide derivatives as prodrugs of COX-2 inhibitors | SEARLE LLC (US) | 2008-09-17 | — | — | EP | disclosed |
| EP-1828164-B1 | METHOD FOR PREPARING N-PHENYLPYRAZOLE-1-CARBOXAMIDES | DU PONT (US) | 2008-09-17 | — | — | EP | disclosed |
| US-7420061-B2 | Process for preparing prodrugs of benzenesulfonamide-containing COX-2 inhibitors | PHARMACIA CORPORATION (US) | 2008-09-02 | — | — | US | disclosed |
| EP-1957458-A2 | 5-(ARYLSULFONYL)-PYRAZOLOPIPERIDINES | Elan Pharmaceuticals Inc. (US) | 2008-08-20 | — | — | EP | disclosed |
| WO-2008064311-A2 | METALLO-OXIDOREDUCTASE INHIBITORS USING METAL BINDING MOIETIES IN COMBINATION WITH TARGETING MOIETIES | VIAMET PHARMACEUTICALS, INC. (US) | 2008-05-29 | — | — | WO | disclosed |
| CN-100390158-C | Novel heterocyclic analogues of diphenylethylene compounds | CALYX THERAPEUTICS INC (US) | 2008-05-28 | — | — | CN | disclosed |
| EP-1910552-A1 | METHODS AND COMPOSITIONS FOR MODULATING COX | Arbor Vita Corporation (US) | 2008-04-16 | — | — | EP | disclosed |
| US-20080085900-A1 | SULFONYLGUANIDINE COMPOUNDS AND PHARMACEUTICAL USES THEREOF | GRUENENTHAL GMBH (DE) | 2008-04-10 | — | — | US | disclosed |
| EP-1908752-A1 | NOVEL 2-QUINOLONE DERIVATIVE | Dainippon Sumitomo Pharma Co., Ltd. (JP) | 2008-04-09 | — | — | EP | disclosed |
| US-20080064690-A1 | PYRAZOLE-AMIDES AND -SULFONAMIDES | ICAGEN, INC. (US) | 2008-03-13 | — | — | US | disclosed |
| US-20070299265-A1 | Method for Preparing N-Phenylpyrazole-1-Carboxamides | FMC CORPORATION | 2007-12-27 | — | — | US | disclosed |
| US-20070281978-A1 | INHIBITORS OF AQUAPORIN 4, METHODS AND USES THEREOF | NIIGATA UNIVERSITY (JP) | 2007-12-06 | — | — | US | disclosed |
| US-20070281978-A1 | INHIBITORS OF AQUAPORIN 4, METHODS AND USES THEREOF | NIIGATA UNIVERSITY (JP) | 2007-12-06 | — | — | US | disclosed |
| US-7300951-B2 | Fluoro- and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof | WYETH (US) | 2007-11-27 | — | — | US | disclosed |
| US-20070254929-A1 | Fluoro-and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof | WYETH (US) | 2007-11-01 | — | — | US | disclosed |
| WO-2007110876-A2 | NOVEL SULFONANILIDE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME AND PROCESS THEREOF | PANACEA BIOTEC LTD. (IN) | 2007-10-04 | — | — | WO | disclosed |
| WO-2007107469-A1 | METHODS OF INHIBITING BTK AND SYK PROTEIN KINASES | F. HOFFMANN-LA ROCHE AG (CH) | 2007-09-27 | — | — | WO | disclosed |
| US-20070219195-A1 | e.g. 4-(5-Methyl-2H-pyrazole-3-ylamino)-phenyl-2H-phthalazin-1-one2-Phenyl-2,3-dihydro-phthalazine-1,4-dione; tyrosine kinase inhibitor; antiinflammatory agent; asthma, rheumatoid arthritis, systemic lupus erythematosus or multiple sclerosis | ROCHE PALO ALTO LLC | 2007-09-20 | — | — | US | disclosed |
| EP-1828164-A1 | METHOD FOR PREPARING N-PHENYLPYRAZOLE-1-CARBOXAMIDES | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2007-09-05 | — | — | EP | disclosed |
| WO-2007098029-A1 | METHODS FOR PREPARING SULFONAMIDE SUBSTITUTED ALCOHOLS AND INTERMEDIATES THEREOF | WYETH (US) | 2007-08-30 | — | — | WO | disclosed |
| WO-2007098030-A1 | SELECTIVE N-SULFONYLATION OF 2-AMINO TRIFLUOROALKYL SUBSTITUTED ALCOHOLS | WYETH (US) | 2007-08-30 | — | — | WO | disclosed |
| US-20070197800-A1 | Selective n-sulfonylation of 2-amino flouro-and trifluoroalkyl substituted alcohols | WYETH (US) | 2007-08-23 | — | — | US | disclosed |
| US-20070197830-A1 | Methods for preparing sulfonamide substituted alcohols and intermediates thereof | WYETH (US) | 2007-08-23 | — | — | US | disclosed |
| EP-1379513-B1 | PRODRUGS OF COX-2 INHIBITORS | PHARMACIA CORP (US) | 2007-08-22 | — | — | EP | disclosed |
| US-20070155753-A1 | 5-(Arylsulfonyl)-Pyrazolopiperidines | ELAN PHARMACEUTICALS, INC. | 2007-07-05 | — | — | US | disclosed |
| EP-1794148-A1 | NOVEL PHTHALAZINONE DERIVATIVES, AS AURORA-A KINASE INHIBITORS | F.HOFFMANN-LA ROCHE AG (CH) | 2007-06-13 | — | — | EP | disclosed |
| WO-2007064914-A2 | 5-(ARYLSULFONYL)-PYRAZOLOPIPERIDINES | ELAN PHARMACEUTICALS, INC. (US) | 2007-06-07 | — | — | WO | disclosed |
| US-7226923-B2 | Phthalazinone derivatives | HOFFMAN-LA ROCHE INC. (US) | 2007-06-05 | — | — | US | disclosed |
| US-7223782-B2 | Pyrazole-amides and -sulfonamides | ICAGEN, INC. (US) | 2007-05-29 | — | — | US | disclosed |
| US-20070020717-A1 | METHODS AND COMPOSITIONS FOR MODULATING COX | ARBOR VITA CORPORATION (US) | 2007-01-25 | — | — | US | disclosed |
| WO-2007002395-A1 | METHODS AND COMPOSITIONS FOR MODULATING COX | ARBOR VITA CORPORATION (US) | 2007-01-04 | — | — | WO | disclosed |
| US-7141599-B2 | Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor, a leukotriene B4 receptor inhibitor and a cyclosporin | PHARMACIA CORPORATION (US) | 2006-11-28 | — | — | US | disclosed |
| US-7132441-B2 | Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor | G.D. SEARLE & CO. (US) | 2006-11-07 | — | — | US | disclosed |
| CN-1812779-A | Compounds for treating inflammation, diabetes and related diseases | THERACOS INC (US) | 2006-08-02 | — | — | CN | disclosed |
| WO-2006062978-A1 | METHOD FOR PREPARING N-PHENYLPYRAZOLE-1-CARBOXAMIDES | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2006-06-15 | — | — | WO | disclosed |
| US-20060089359-A1 | Phthalazinone derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 2006-04-27 | — | — | US | disclosed |
| US-20060074082-A1 | (Arylamidoaryl)cyanoguanidine compounds | OSI PHARMACEUTICALS, INC. | 2006-04-06 | — | — | US | disclosed |
| WO-2006032518-A1 | NOVEL PHTHALAZINONE DERIVATIVES, AS AURORA-A KINASE INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2006-03-30 | — | — | WO | disclosed |
| WO-2006034110-A1 | (ARYLAMIDOARYL) CYANOGUANIDINE COMPOUNDS AS INHIBITORS OF C-KIT PROTO-ONCOGENE | OSI PHARMACEUTICALS, INC. (US) | 2006-03-30 | — | — | WO | disclosed |
| EP-1640003-A2 | Compositions comprising a Cyclooxygenase-2 Inhibitor and a Leukotriene B4 receptor antagonist | G.D. SEARLE & CO. (US) | 2006-03-29 | — | — | EP | disclosed |
| EP-1620405-A2 | PYRAZOLE-AMIDES AND SULFONAMIDES AS SODIUM CHANNEL MODULATORS | Abbott Laboratories (US) | 2006-02-01 | — | — | EP | disclosed |
| EP-1608638-A1 | FLUORO-AND TRIFLUOROALKYL-CONTAINING HETEROCYCLIC SULFONAMIDE INHIBITORS OF BETA AMYLOID PRODUCTION AND DERIVATIVES THEREOF | Wyeth (US) | 2005-12-28 | — | — | EP | disclosed |
| CN-1708486-A | Novel heterocyclic analogues of diphenylethylene compounds | THERACOS INC (US) | 2005-12-14 | — | — | CN | disclosed |
| CN-1688288-A | Preparation of submicron sized particles with polymorph control and new polymorph of itraconazole | BAXTER INT (US) | 2005-10-26 | — | — | CN | disclosed |
| EP-0880362-B1 | COMPOSITIONS COMPRISING A CYCLOOXYGENASE-2 INHIBITOR AND A LEUKOTRIENE B 4 RECEPTOR ANTAGONIST | SEARLE & CO (US) | 2005-05-25 | — | — | EP | disclosed |
| CN-1615295-A | Compounds for the treatment of inflammation, diabetes and related disorders | THERACOS INC (US) | 2005-05-11 | — | — | CN | disclosed |
| EP-1451160-A4 | PYRAZOLE-AMIDES AND-SULFONAMIDES | ICAGEN INC (US) | 2005-04-20 | — | — | EP | disclosed |
| US-20050049237-A1 | Pyrazole-amides and -sulfonamides | ICAGEN, INC. (US) | 2005-03-03 | — | — | US | disclosed |
| US-20050043355-A1 | Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor | PHARMACIA CORPORATION | 2005-02-24 | — | — | US | disclosed |
| US-20050032852-A1 | Prodrugs of cox-2 inhibitors | CARTER JEFFERY S (US) | 2005-02-10 | — | — | US | disclosed |
| US-20050032851-A1 | Process for preparing prodrugs of benzenesulfonamide-containing COX-2 inhibitors | PHARMACIA CORPORATION | 2005-02-10 | — | — | US | disclosed |
| US-20050020564-A1 | Pyrazole-amides and sulfonamides as sodium channel modulators | ABBOTT LABORATORIES | 2005-01-27 | — | — | US | disclosed |
| WO-2004099154-A2 | PYRAZOLE-AMIDES AND SULFONAMIDES AS SODIUM CHANNEL MODULATORS | ABBOTT LABORATORIES (US) | 2004-11-18 | — | — | WO | disclosed |
| US-6815460-B2 | Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors | PHARMACIA CORPORATION | 2004-11-09 | — | — | US | disclosed |
| US-20040220170-A1 | Pyrazole-amides and sulfonamides as sodium channel modulators | ABBOTT LABORATORIES | 2004-11-04 | — | — | US | disclosed |
| WO-2004092155-A1 | FLUORO-AND TRIFLUOROALKYL-CONTAINING HETEROCYCLIC SULFONAMIDE INHIBITORS OF BETA AMYLOID PRODUCTION AND DERIVATIVES THEREOF | WYETH (US) | 2004-10-28 | — | — | WO | disclosed |
| US-6809111-B2 | ANTIINFLAMMATORY AGENTS; ANALGESICS | PHARMACIA CORPORATION | 2004-10-26 | — | — | US | disclosed |
| CN-1537002-A | Novel heterocyclic analogues of diphenylethylene compounds | �Ƹ��� | 2004-10-13 | — | — | CN | disclosed |
| US-20040197429-A1 | Selective COX-2 inhibition from plant extracts | PHARMACIA CORPORATION | 2004-10-07 | — | — | US | disclosed |
| US-20040198778-A1 | Fluoro- and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof | WYETH | 2004-10-07 | — | — | US | disclosed |
| US-20040185122-A1 | Selective COX-2 inhibition from edible plant extracts | PHARMACIA CORPORATION | 2004-09-23 | — | — | US | disclosed |
| EP-1451160-A2 | PYRAZOLE-AMIDES AND-SULFONAMIDES | Icagen, Inc. (US) | 2004-09-01 | — | — | EP | disclosed |
| US-20040126438-A1 | Selective cox-2 inhibition from plant extracts | OBUKOWICZ MARK G (US) | 2004-07-01 | — | — | US | disclosed |
| US-20040106668-A1 | Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor, a leukotriene B4 receptor inhibitor and a cyclosporin | PHARMACIA CORPORATION | 2004-06-03 | — | — | US | disclosed |
| US-20040062823-A1 | Selective cox-2 inhibition from non-edible plant extracts | OBUKOWICZ MARK G (US) | 2004-04-01 | — | — | US | disclosed |
| EP-1401461-A2 | SELECTIVE COX-2 INHIBITION FROM EDIBLE PLANT EXTRACTS | Pharmacia Corporation (US) | 2004-03-31 | — | — | EP | disclosed |
| EP-1401460-A2 | SELECTIVE COX-2 INHIBITION FROM PLANT EXTRACTS | Pharmacia Corporation (US) | 2004-03-31 | — | — | EP | disclosed |
| US-20040052870-A1 | Selective cox-2 inhibition from edible plant extracts | OBUKOWICZ MARK G (US) | 2004-03-18 | — | — | US | disclosed |
| EP-1379513-A1 | PRODRUGS OF COX-2 INHIBITORS | Pharmacia Corporation (US) | 2004-01-14 | — | — | EP | disclosed |
| US-20040002522-A1 | Prodrugs of COX-2 inhibitors | PHARMACIA CORPORATION | 2004-01-01 | — | — | US | disclosed |
| US-20030225084-A1 | Sulfonylguanidine compounds and pharmaceutical uses thereof | GRUENENTHAL GMBH (DE) | 2003-12-04 | — | — | US | disclosed |
| EP-1363649-A1 | SELECTIVE COX-2 INHIBITION FROM NON-EDIBLE PLANT EXTRACTS | Pharmacia Corporation (US) | 2003-11-26 | — | — | EP | disclosed |
| US-6617345-B1 | Cyclooxygenase-2 inhibitor is (5-bromo-2-(4-fluorophenyl )-3-(4-(methylsulfonyl)phey)-thiophene), N-(2-(cyclohexyloxy 4-nitrophenyl)-methanesulfonamide), meloxicam, flosulide or cyclic substituted phenyl sulfones or sulfonamides | G.D. SEARLE & CO. | 2003-09-09 | — | — | US | disclosed |
| US-6613790-B2 | For therapy of cyclooxygenase-2 mediated disease | PHARMACIA CORPORATION | 2003-09-02 | — | — | US | disclosed |
| US-6576664-B1 | 1-amido-2-hydroxy-substituted-indanes; suppressing production of tumor necrosis factor | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2003-06-10 | — | — | US | disclosed |
| WO-2003037274-A2 | PYRAZOLE-AMIDES AND-SULFONAMIDES | ICAGEN, INC. (US) | 2003-05-08 | — | — | WO | disclosed |
| US-20030069287-A1 | Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors | PHARMACIA CORPORATION | 2003-04-10 | — | — | US | disclosed |
| EP-1299122-A2 | COMBINATION OF A COX-2 INHIBITOR AND A VASOMODULATOR FOR TREATING PAIN AND HEADACHE PAIN | Pharmacia Corporation (US) | 2003-04-09 | — | — | EP | disclosed |
| US-20030055012-A1 | Prodrugs of COX-2 inhibitors | PHARMACIA CORPORATION | 2003-03-20 | — | — | US | disclosed |
| EP-1288206-A1 | Substituted benzenesulfonamide derivatives as prodrugs of COX-2 inhibitors | G.D. SEARLE & CO. (US) | 2003-03-05 | — | — | EP | disclosed |
| EP-0892791-B1 | N-[[4-(5-METHYL-3-PHENYLISOXAZOL-4-YL]PHENYL]SULFONYLPROPYLAMIDE and its SODIUMSALT AS PRODRUGS OF COX-2 INHIBITORS | SEARLE & CO (US) | 2003-03-05 | — | — | EP | disclosed |
| US-20030004191-A1 | Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor | PHARMACIA CORPORATION | 2003-01-02 | — | — | US | disclosed |
| WO-2002083655-A1 | PRODRUGS OF COX-2 INHIBITORS | PHARMACIA CORPORATION (US) | 2002-10-24 | — | — | WO | disclosed |
| US-20020143033-A1 | Immunosuppresive effects of administration of a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor | G.D. SEARLE & CO. | 2002-10-03 | — | — | US | disclosed |
| US-20020136784-A1 | Selective COX-2 inhibition from plant extracts | PHARMACIA CORPORATION | 2002-09-26 | — | — | US | disclosed |
| EP-0880363-B1 | COMBINATIONS, HAVING IMMUNOSUPPRESSIVE EFFECTS, CONTAINING A CYCLOOXYGENASE-2 INHIBITOR AND A LEUKOTRIENE A 4 HYDROLASE INHIBITOR | SEARLE & CO (US) | 2002-09-11 | — | — | EP | disclosed |
| US-20020122836-A1 | Selective COX-2 inhibition from non-edible plant extracts | PHARMACIA CORPORATION | 2002-09-05 | — | — | US | disclosed |
| US-6436967-B1 | PREFERENTIAL CYCLOOXYGENASE INHIBITORS USED AS INJECTABLE ANALGESIC AND ANTIINFLAMMATORY AGENTS HAVING REDUCED SIDE EFFECTS; ACYLATION | PHARMACIA CORPORATION | 2002-08-20 | — | — | US | disclosed |
| WO-2002047706-A2 | SELECTIVE COX-2 INHIBITION FROM PLANT EXTRACTS | PHARMACIA CORPORATION (US) | 2002-06-20 | — | — | WO | disclosed |
| WO-2002047708-A2 | SELECTIVE COX-2 INHIBITION FROM EDIBLE PLANT EXTRACTS | PHARMACIA CORPORATION (US) | 2002-06-20 | — | — | WO | disclosed |
| US-20020077328-A1 | Selective cyclooxygenase-2 inhibitors and vasomodulator compounds for generalized pain and headache pain | PHARMACIA CORPORATION | 2002-06-20 | — | — | US | disclosed |
| WO-2002047707-A2 | SELECTIVE COX-2 INHIBITION FROM NON-EDIBLE PLANT EXTRACTS | PHARMACIA CORPORATION (US) | 2002-06-20 | — | — | WO | disclosed |
| US-6407140-B1 | AUTOIMMUNE DISEASES, GRAFT VERSUS HOST DISEASE AND ORGAN TRANSPLANT SURGERY; PYRAZOLE DERIVATIVE MIXTURE | G.D. SEARLE & CO. | 2002-06-18 | — | — | US | disclosed |
| US-6376528-B1 | SYNERGISTIC MIXTURE | G. D. SEARLE & CO. | 2002-04-23 | — | — | US | disclosed |
| US-6372774-B1 | THESE COMPOUNDS POSSESS ARTHROPODICIDAL, PLANT NEMATOCIDAL, ANTHELMINTIC AND ANTI-PROTOZOAL PROPERTIES | RHONE-POULENC AGRICULTURE LTD. (GB) | 2002-04-16 | — | — | US | disclosed |
| WO-2002005799-A2 | COMBINATION OF A COX-2 INHIBITOR AND A VASOMODULATOR FOR TREATING PAIN AND HEADACHE PAIN | PHARMACIA CORPORATION (US) | 2002-01-24 | — | — | WO | disclosed |
| EP-0888127-B1 | COMBINATIONS HAVING IMMUNOSUPPRESSIVE EFFECTS, CONTAINING CYCLOOXYGENASE-2-INHIBITORS AND 5-LIPOXYGENASE INHIBITORS | SEARLE & CO (US) | 2001-12-12 | — | — | EP | disclosed |
| US-20010024664-A1 | Selective COX-2 inhibition from edible plant extracts | PHARMACIA CORPORATION | 2001-09-27 | — | — | US | disclosed |
| EP-1100334-A1 | HERBICAL MIXTURES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2001-05-23 | — | — | EP | disclosed |
| US-6172096-B1 | ADMINISTERING 4-PYRAZOLYLBENZENESULFONAMIDE DERIVATIVES TO TREAT AUTOIMMUNE DISEASES | G. D. SEARLE & CO. | 2001-01-09 | — | — | US | disclosed |
| EP-0726268-B1 | Substituted benzisoxazole and benzisothiazole herbicidal agents | AMERICAN CYANAMID CO (US) | 2000-11-02 | — | — | EP | disclosed |
| US-6114283-A | SYNERGISTIC | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2000-09-05 | — | — | US | disclosed |
| CN-1055686-C | Substituted Benzisoxazole and benzisothiazole herbicidal agents | AMERICAN CYANAMID CO (US) | 2000-08-23 | — | — | CN | disclosed |
| WO-2000005958-A1 | HERBICIDAL MIXTURES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2000-02-10 | — | — | WO | disclosed |
| US-5932598-A | NOVEL SUBSTITUTED SULFONAMIDE COMPOUNDS USEFUL AS PRODRUGS; ADMINISTERING TO TREAT INFLAMMATION-ASSOCIATED PAIN DUE TO CANCER, DENTAL PAIN; CYCLOOXYGENASE-2 INHIBITORS | G. D. SEARLE & CO. (US) | 1999-08-03 | — | — | US | disclosed |
| US-5916618-A | PESTICIDE FOR MEDICATED FEEDSTUFF, DIETARY CONCENTRATE OR SUPPLEMENT | RHONE-POULENC AGRICULTURE LTD. (GB) | 1999-06-29 | — | — | US | disclosed |
| EP-0890311-A2 | Herbicidal mixtures | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1999-01-13 | — | — | EP | disclosed |
| EP-0888127-A1 | COMBINATIONS HAVING IMMUNOSUPPRESSIVE EFFECTS, CONTAINING CYCLOOXYGENASE-2-INHIBITORS AND 5-LIPOXYGENASE INHIBITORS | G.D. SEARLE & CO. (US) | 1999-01-07 | — | — | EP | disclosed |
| WO-1998058545-A1 | HERBICIDAL MIXTURES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1998-12-30 | — | — | WO | disclosed |
| EP-0880362-A1 | COMPOSITIONS COMPRISING A CYCLOOXYGENASE-2 INHIBITOR AND A LEUKOTRIENE B 4 RECEPTOR ANTAGONIST | G.D. SEARLE & CO. (US) | 1998-12-02 | — | — | EP | disclosed |
| EP-0880363-A1 | COMBINATIONS, HAVING IMMUNOSUPPRESSIVE EFFECTS, CONTAINING A CYCLOOXYGENASE-2 INHIBITOR AND A LEUKOTRIENE A 4? HYDROLASE INHIBITOR | G.D. SEARLE & CO. (US) | 1998-12-02 | — | — | EP | disclosed |
| US-5798317-A | SYNERGISTIC | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1998-08-25 | — | — | US | disclosed |
| US-5736486-A | Herbicidal mixture of anilofos and propanil | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1998-04-07 | — | — | US | disclosed |
| CN-1173112-A | Herbicidal mixtures | DU PONT (US) | 1998-02-11 | — | — | CN | disclosed |
| US-5714191-A | PESTICIDES USED IN MEDICATED FEEDSTUFF, MINERAL SALT LICK OR EDIBLE BAIT | RHONE-POULENC AGRICULTURE LTD. (GB) | 1998-02-03 | — | — | US | disclosed |
| WO-1997038986-A1 | SUBSTITUTED BENZENESULFONAMIDE DERIVATIVES AS PRODRUGS OF COX-2 INHIBITORS | G.D. SEARLE & CO. (US) | 1997-10-23 | — | — | WO | disclosed |
| EP-0792103-A2 | HERBICIDAL MIXTURES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1997-09-03 | — | — | EP | disclosed |
| WO-1997029776-A1 | COMBINATIONS HAVING IMMUNOSUPPRESSIVE EFFECTS, CONTAINING CYCLOOXYGENASE-2-INHIBITORS AND 5-LIPOXYGENASE INHIBITORS | G.D. SEARLE & CO. (US) | 1997-08-21 | — | — | WO | disclosed |
| WO-1997029775-A1 | COMPOSITIONS COMPRISING A CYCLOOXYGENASE-2 INHIBITOR AND A LEUKOTRIENE B4 RECEPTOR ANTAGONIST | G.D. SEARLE & CO. (US) | 1997-08-21 | — | — | WO | disclosed |
| WO-1997029774-A1 | COMBINATIONS, HAVING IMMUNOSUPPRESSIVE EFFECTS, CONTAINING A CYCLOOXYGENASE-2 INHIBITOR AND A LEUKOTRIENE A4 HYDROLASE INHIBITOR | G.D. SEARLE & CO. (US) | 1997-08-21 | — | — | WO | disclosed |
| WO-1997007678-A1 | HERBICIDAL MIXTURES FOR PADDY FIELDS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1997-03-06 | — | — | WO | disclosed |
| US-5608077-A | INSECTICIDES, NEMATOCIDES, ANTHELMINTICS, ANTIPROTOZOA AGENTS | RHONE-POULENC AGRICULTURE LTD. (GB) | 1997-03-04 | — | — | US | disclosed |
| CN-1136561-A | Substituted Benzisoxazole and benzisothiazole herbicidal agents | AMERICAN CYANAMID CO (US) | 1996-11-27 | — | — | CN | disclosed |
| US-5547974-A | INSECTICIDES, NEMATOCIDES, ANTHELMINTICS | RHONE-POULENC AGRICULTURE LTD. (GB) | 1996-08-20 | — | — | US | disclosed |
| EP-0726268-A1 | Substituted benzisoxazole and benzisothiazole herbicidal agents | American Cyanamid Company (US) | 1996-08-14 | — | — | EP | disclosed |
| US-5523278-A | PRE- AND POST-EMERGENCE HERBICIDES | AMERICAN CYANAMID COMPANY (US) | 1996-06-04 | — | — | US | disclosed |
| WO-1996013977-A2 | HERBICIDAL MIXTURES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-05-17 | — | — | WO | disclosed |
| EP-0579280-B1 | Pesticidal method using N-phenylpyrazoles | RHONE POULENC AGROCHIMIE (FR) | 1996-02-28 | — | — | EP | disclosed |
| US-5484763-A | Substituted benzisoxazole and benzisothiazole herbicidal agents | AMERICAN CYANAMID COMPANY (US) | 1996-01-16 | — | — | US | disclosed |
| EP-0087780-B2 | Pyrazolesulfonylurea derivative, preparation thereof, herbicide containing said derivative as active ingredient and herbicidal method by use thereof | NISSAN CHEMICAL IND LTD (JP) | 1995-02-15 | — | — | EP | disclosed |
| EP-0249938-B1 | Imidazolesulfonamide derivatives, herbicides and a method for inhibiting growth of undesirable plants | NISSAN CHEMICAL IND LTD (JP) | 1994-12-14 | — | — | EP | disclosed |
| EP-0095925-B2 | Herbicidal imidazole, pyrazole, thiazole and isothiazole derivatives | DU PONT (US) | 1994-12-07 | — | — | EP | disclosed |
| US-5356862-A | Herbicidal sulfonylureas | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1994-10-18 | — | — | US | disclosed |
| US-5354731-A | Pyridinesulfonamide derivatives as herbicides | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1994-10-11 | — | — | US | disclosed |
| CN-1025811-C | Pesticidal method using N-phenyl pyrazoles | MAY & BAKER LTD (GB) | 1994-09-07 | — | — | CN | disclosed |
| EP-0234119-B1 | Pesticidal method using N-phenylpyrazoles | RHONE POULENC AGROCHIMIE (FR) | 1994-08-24 | — | — | EP | disclosed |
| EP-0579280-A1 | Pesticidal method using N-phenylpyrazoles | RHONE-POULENC AGROCHIMIE (FR) | 1994-01-19 | — | — | EP | disclosed |
| JP-H069314-A | HERBICIDE | DU PONT JAPAN LTD | 1994-01-18 | — | — | JP | disclosed |
| US-5232940-A | Controlling insects, plant nematodes, helminths, protozoa | BASF AGRO B.V., ARNHEM (NL), WADENSWIL-BRANCH (CH) | 1993-08-03 | — | — | US | disclosed |
| EP-0318602-B1 | PYRAZOLESULFONAMIDE DERIVATIVE, PROCESS FOR ITS PRODUCTION AND HERBICIDE CONTAINING IT | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1993-04-28 | — | — | EP | disclosed |
| EP-0318602-B1 | PYRAZOLESULFONAMIDE DERIVATIVE, PROCESS FOR ITS PRODUCTION AND HERBICIDE CONTAINING IT | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1993-04-28 | — | — | EP | disclosed |
| EP-0511993-A1 | HERBICIDAL SULFONYLUREAS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-11-11 | — | — | EP | disclosed |
| US-5116405-A | Herbicides for crops | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1992-05-26 | — | — | US | disclosed |
| EP-0224842-B1 | PYRAZOLESULFONAMIDE DERIVATIVE, PROCESS FOR ITS PRODUCTION AND HERBICIDE CONTAINING IT | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1992-02-05 | — | — | EP | disclosed |
| EP-0224842-B1 | PYRAZOLESULFONAMIDE DERIVATIVE, PROCESS FOR ITS PRODUCTION AND HERBICIDE CONTAINING IT | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1992-02-05 | — | — | EP | disclosed |
| CN-1015107-B | Process for producing pyrimidine or triazine derivative | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1991-12-18 | — | — | CN | disclosed |
| WO-1991010668-A1 | HERBICIDAL SULFONYLUREAS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-07-25 | — | — | WO | disclosed |
| EP-0176304-B1 | HERBICIDAL PYRAZOLESULFONAMIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-06-05 | — | — | EP | disclosed |
| EP-0176304-B1 | HERBICIDAL PYRAZOLESULFONAMIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-06-05 | — | — | EP | disclosed |
| CN-1051731-A | Herbicidal compound, its preparation method and methods for using them | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1991-05-29 | — | — | CN | disclosed |
| US-5017214-A | Herbicidal sulfonamides | LEVITT GEORGE (US) | 1991-05-21 | — | — | US | disclosed |
| EP-0427174-A1 | Pyridinesulfonamide derivatives and herbicides | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1991-05-15 | — | — | EP | disclosed |
| EP-0187489-B1 | HERBICIDAL SULFONAMIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-12-12 | — | — | EP | disclosed |
| US-4954164-A | Pyrazolesulfonylurea derivatives, preparation thereof, herbicide containing said derivative as active ingredient and herbicidal method by use thereof | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 1990-09-04 | — | — | US | disclosed |
| EP-0155767-B1 | HERBICIDAL SULFONAMIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-08-16 | — | — | EP | disclosed |
| EP-0178101-B1 | HERBICIDAL ORTHO-HETEROCYCLIC SULFONAMIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-05-16 | — | — | EP | disclosed |
| US-4917719-A | PLANT GROWTH REGULANTS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-04-17 | — | — | US | disclosed |
| US-4913726-A | PLANT GROWTH REGULATORS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-04-03 | — | — | US | disclosed |
| US-4897108-A | Herbicidal sulfonamides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-01-30 | — | — | US | disclosed |
| US-4895590-A | Herbicidal pyrazolesulfonamides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-01-23 | — | — | US | disclosed |
| US-4895590-A | Herbicidal pyrazolesulfonamides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-01-23 | — | — | US | disclosed |
| US-4895590-A | Herbicidal pyrazolesulfonamides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-01-23 | — | — | US | disclosed |
| US-4881965-A | CONTROLLING WILD OATS | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 1989-11-21 | — | — | US | disclosed |
| US-4872901-A | PREFERENTIAL | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1989-10-10 | — | — | US | disclosed |
| EP-0333304-A2 | Herbicidal sulfonamides | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1989-09-20 | — | — | EP | disclosed |
| US-4867783-A | CONTAINING A THREE OR FOUR MEMBER RING | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1989-09-19 | — | — | US | disclosed |
| US-4846878-A | Herbicidal pyrazole sulfonamides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1989-07-11 | — | — | US | disclosed |
| US-4844728-A | Pyrazolesulfonamide derivative, and herbicide containing it | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 1989-07-04 | — | — | US | disclosed |
| US-4844728-A | Pyrazolesulfonamide derivative, and herbicide containing it | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 1989-07-04 | — | — | US | disclosed |
| US-4844728-A | Pyrazolesulfonamide derivative, and herbicide containing it | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 1989-07-04 | — | — | US | disclosed |
| EP-0318602-A1 | Pyrazolesulfonamide derivative, process for its production and herbicide containing it | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1989-06-07 | — | — | EP | disclosed |
| EP-0318602-A1 | Pyrazolesulfonamide derivative, process for its production and herbicide containing it | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1989-06-07 | — | — | EP | disclosed |
| EP-0318602-A1 | Pyrazolesulfonamide derivative, process for its production and herbicide containing it | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1989-06-07 | — | — | EP | disclosed |
| US-4786311-A | Herbicidal sulfonamides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1988-11-22 | — | — | US | disclosed |
| US-4769060-A | Herbicidal sulfonamides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1988-09-06 | — | — | US | disclosed |
| US-4762550-A | Herbicidal pyrazolesulfonamides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1988-08-09 | — | — | US | disclosed |
| US-4762550-A | Herbicidal pyrazolesulfonamides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1988-08-09 | — | — | US | disclosed |
| US-4762550-A | Herbicidal pyrazolesulfonamides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1988-08-09 | — | — | US | disclosed |
| US-4747870-A | Herbicidal pyrazole sulfonamides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1988-05-31 | — | — | US | disclosed |
| US-4746353-A | Herbicidal sulfonamides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1988-05-24 | — | — | US | disclosed |
| US-4743292-A | Herbicidal sulfonamides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1988-05-10 | — | — | US | disclosed |
| US-4743292-A | Herbicidal sulfonamides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1988-05-10 | — | — | US | disclosed |
| US-4732604-A | Herbicidal sulfonamides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1988-03-22 | — | — | US | disclosed |
| US-4715886-A | PRE- AND POSTEMERGENCE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-12-29 | — | — | US | disclosed |
| US-4715886-A | PRE- AND POSTEMERGENCE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-12-29 | — | — | US | disclosed |
| US-4715886-A | PRE- AND POSTEMERGENCE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-12-29 | — | — | US | disclosed |
| US-4707178-A | PLANT GROWTH REGULATORS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-11-17 | — | — | US | disclosed |
| US-4707178-A | PLANT GROWTH REGULATORS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-11-17 | — | — | US | disclosed |
| US-4707178-A | PLANT GROWTH REGULATORS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-11-17 | — | — | US | disclosed |
| US-4705558-A | Herbicidal pyrazolesulfonamides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-11-10 | — | — | US | disclosed |
| US-4705558-A | Herbicidal pyrazolesulfonamides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-11-10 | — | — | US | disclosed |
| US-4705558-A | Herbicidal pyrazolesulfonamides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-11-10 | — | — | US | disclosed |
| US-4693743-A | Herbicidal sulfonamides | E. I. DU PONT DE NEMOURS & COMPANY (US) | 1987-09-15 | — | — | US | disclosed |
| EP-0234119-A1 | Pesticidal method using N-phenylpyrazoles | RHONE-POULENC AGROCHIMIE (FR) | 1987-09-02 | — | — | EP | disclosed |
| US-4689417-A | HERBICIDE INTERMEDIATES | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 1987-08-25 | — | — | US | disclosed |
| WO-1987003781-A1 | PESTICIDAL METHOD USING N-PHENYLPYRAZOLES | MAY & BAKER LIMITED (GB) | 1987-07-02 | — | — | WO | disclosed |
| EP-0224842-A2 | Pyrazolesulfonamide derivative, process for its production and herbicide containing it | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1987-06-10 | — | — | EP | disclosed |
| EP-0224842-A2 | Pyrazolesulfonamide derivative, process for its production and herbicide containing it | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1987-06-10 | — | — | EP | disclosed |
| EP-0224842-A2 | Pyrazolesulfonamide derivative, process for its production and herbicide containing it | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1987-06-10 | — | — | EP | disclosed |
| US-4671817-A | Herbicidal pyrazole sulfonamides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-06-09 | — | — | US | disclosed |
| US-4671817-A | Herbicidal pyrazole sulfonamides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-06-09 | — | — | US | disclosed |
| US-4671817-A | Herbicidal pyrazole sulfonamides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-06-09 | — | — | US | disclosed |
| CN-86107113-A | Herbicidal compounds, process for their preparation and their use | — | 1987-05-27 | — | — | CN | disclosed |
| US-4668277-A | HERBICIDES | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 1987-05-26 | — | — | US | disclosed |
| US-4666501-A | PLANT GROWTH REGULANTS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-05-19 | — | — | US | disclosed |
| EP-0220695-A1 | Herbicidal compounds, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1987-05-06 | — | — | EP | disclosed |
| US-4661147-A | PLANT GROWTH REGULATORS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-04-28 | — | — | US | disclosed |
| US-4655817-A | PLANT GROWTH REGULATORS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-04-07 | — | — | US | disclosed |
| US-4655817-A | PLANT GROWTH REGULATORS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-04-07 | — | — | US | disclosed |
| US-4655817-A | PLANT GROWTH REGULATORS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-04-07 | — | — | US | disclosed |
| EP-0189069-A3 | PYRAZOLESULFONAMIDE DERIVATIVE, PROCESS FOR ITS PRODUCTION AND HERBICIDE CONTAINING IT | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1986-12-30 | — | — | EP | disclosed |
| EP-0189069-A3 | PYRAZOLESULFONAMIDE DERIVATIVE, PROCESS FOR ITS PRODUCTION AND HERBICIDE CONTAINING IT | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1986-12-30 | — | — | EP | disclosed |
| US-4622062-A | Herbicidal N-[(4,6-substituted pyrimidin-2-yl)aminocarbonyl]-substituted fused pyrazole-3-sulfonamides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-11-11 | — | — | US | disclosed |
| CN-86100911-A | The preparation method of pyrazoles sulfone amide derivative and the weedicide that contains this kind derivative | — | 1986-09-24 | — | — | CN | disclosed |
| US-4609397-A | PRE- AND POSTEMERGENCE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-09-02 | — | — | US | disclosed |
| US-4604130-A | Herbicidal N-[pyrimidine aminocarbonyl]isothiazole sulfonamides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-08-05 | — | — | US | disclosed |
| EP-0189069-A2 | Pyrazolesulfonamide derivative, process for its production and herbicide containing it | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1986-07-30 | — | — | EP | disclosed |
| EP-0189069-A2 | Pyrazolesulfonamide derivative, process for its production and herbicide containing it | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1986-07-30 | — | — | EP | disclosed |
| EP-0189069-A2 | Pyrazolesulfonamide derivative, process for its production and herbicide containing it | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1986-07-30 | — | — | EP | disclosed |
| EP-0187489-A1 | Herbicidal sulfonamides | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-07-16 | — | — | EP | disclosed |
| EP-0178101-A1 | Herbicidal ortho-heterocyclic sulfonamides | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-04-16 | — | — | EP | disclosed |
| EP-0176304-A1 | Herbicidal pyrazolesulfonamides | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-04-02 | — | — | EP | disclosed |
| EP-0176304-A1 | Herbicidal pyrazolesulfonamides | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-04-02 | — | — | EP | disclosed |
| EP-0176304-A1 | Herbicidal pyrazolesulfonamides | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-04-02 | — | — | EP | disclosed |
| EP-0165003-A2 | Herbicidal sulfonamides | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1985-12-18 | — | — | EP | disclosed |
| EP-0155767-A1 | Herbicidal sulfonamides | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1985-09-25 | — | — | EP | disclosed |
| EP-0087780-A2 | Pyrazolesulfonylurea derivative, preparation thereof, herbicide containing said derivative as active ingredient and herbicidal method by use thereof | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1983-09-07 | — | — | EP | disclosed |
| EP-0087780-A2 | Pyrazolesulfonylurea derivative, preparation thereof, herbicide containing said derivative as active ingredient and herbicidal method by use thereof | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1983-09-07 | — | — | EP | disclosed |